Home » Trials » SLCTR/2021/021
A single-center, randomized, six month, parallel-group, study to compare the effectiveness of a combination of physiotherapy and Ayurveda treatment versus physiotherapy and placebo in ischemic stroke rehabilitation.
-
SLCTR Registration Number
SLCTR/2021/021
Date of Registration
The date of last modification
Nov 11, 2024
View original TRDS
Trial Status
Scientific Title of Trial
A single-center, randomized, six month, parallel-group, study to compare the effectiveness of a combination of physiotherapy and Ayurveda treatment versus physiotherapy and placebo in ischemic stroke rehabilitation.
Public Title of Trial
Effectiveness of physiotherapy combined with standard Ayurveda treatments (a personalized treatment regime with a combination of Kashaya, Arishta, pills and oils) versus physiotherapy with placebo in improving functional activities in ischemic stroke patients: A Randomized Controlled Trial
Disease or Health Condition(s) Studied
Ischemic stroke
Scientific Acronym
None
Public Acronym
None
Brief title
Effectiveness of physiotherapy combined with Ayurveda treatments in ischemic stroke rehabilitation
Universal Trial Number
U1111-1268-0430
Any other number(s) assigned to the trial and issuing authority
ERC/2021/13: Rajarata University
What is the research question being addressed?
Is physiotherapy combined with Ayurveda treatment effective than physiotherapy and placebo in improving functional activities and ambulation in ischemic stroke patients?
Type of study
Interventional
Study design
Allocation
Randomized controlled trial
Masking
Single blinded : Participants
Control
Placebo
Assignment
Parallel
Purpose
Treatment
Study Phase
Phase 2
Intervention(s) planned
-The study will be a randomized, participant blinded, placebo-controlled clinical trial. It will be conducted at the Ward 61 & 62, Professorial Unit, Teaching Hospital, Anuradhapura, Sri Lanka.
-Eligible participants will be randomized in to two groups (Control group or Experimental group) with a 1:1 allocation ratio by using minimization technique. Participants will remain blinded to treatment allocation until the outcomes are analyzed.
-Control group (Group A) will undergo usual physiotherapy care with placebo Ayurveda treatments. Black tea will be used as placebo Kashaya and Arishta. Finger millet powder and wheat flour will be used to make placebo pills. Coconut oil will be used as placebo oils. Treatments will be continued up to six months.
Doses of interventions are as follows,
Physiotherapy All the exercises will be done for 5-15 repetitions, 2 sets with 10 seconds hold once a day for 5 consecutive days per week. Number of repetitions could be varying according to the individual’s disability level.
Ayurveda medications Kashaya • Denimba Kashaya • Dasamul Kashaya
Add 8 cups (2L) of Kashaya to 250 ml of water and boiled it until it reduces to 1 cup (250ml). Then, 125ml – mane 125 ml - nocte
Arishta • Dasa mul Arishtaya • Bala Arishtaya • Ashwagandha Arishtaya 12.5-25 ml tds
Pills • Yoga raja gugguluwa • Chandraprabha wati • Chandra kalkaya • Ashwagandha gruthaya • Thripala 1-2 pills tds (1 pill=5g)
Oils • Watha widuranga tahilaya • Mahanarayana thailaya • Ashwagandha thailaya
External application, massaging and fomenting of dorsal aspect of limbs of the affected side for 30 minutes on a daily basis.
Same dosing regimen will be used in the control group using the relevant placebo component.
Discharge plan (for both groups) Discharge will be decided by the on-call consultant physician (ward 61 & 62). There won’t be any extended hospital stay for the participants who are included in the study. After discharging, review visits and home treatment programs will be carried out.
-After discharging from the hospital, all participants will be advised to visit the hospital on two weekly bases until the completion of three months for follow up and at the end of three months, hospital follow up visits will be reduced to one visit per month till the completion of six months.
-All participants will be asked to continue their treatment program daily at home and adherence to treatment is checked by regular phone calls and by asking the patient to maintain a treatment diary.
-Ayurveda treatments will be given by a member in the study team who is a consultant physician and a diploma holder in Ayurveda and has registration in practicing Ayurveda and traditional medicine at Ayurveda Education and Hospital Board of Department of Ayurveda, under the Ministry of Health and Indigenous Medicine, Sri Lanka.
-Confirmation of the recruitment will be done by a consultant physician who is one of the members in the study team.
Inclusion criteria
• Patients confirmed to have an ischemic stroke • Patients above 18 years of age * Both men and women • Barthel Index 0-50 (severely disabled patients) • NIHSS score (The National Institutes of Health Stroke Scale Score) 5-20 on admission. • Non- thrombolysis patients
Exclusion criteria
• Stroke mimics (A nonvascular disease that presents with stroke-like symptoms, often indistinguishable from an actual stroke) Eg: brain tumors (gliomas, meningiomas, adenomas)
Primary outcome(s)
1.
% change in global disability using Barthel Index |
[ At the baseline, at the end of three months and six months of starting the treatments ] |
Secondary outcome(s)
1.
% change in motor functions using the Motor Assessment Scale (MAS) |
[ At the baseline, at the end of three months and six months of starting the treatments ] |
2.
% change in risk of falls using the Berg Balance Scale (BBS) |
[ At the baseline, at the end of three months and six months of starting the treatments ] |
3.
% change in ability to walk independently using New Functional Ambulation Category (FAC) |
[ At the baseline, at the end of three months and six months of starting the treatments ] |
4.
|
[] |
5.
|
[] |
Target number/sample size
94 (47 in each arm)
Countries of recruitment
Sri Lanka
Anticipated start date
2021-07-30
Anticipated end date
2023-06-29
Date of first enrollment
2021-08-18
Date of study completion
Recruitment status
Terminated
Funding source
Research Grants Committee, Rajarata University of Sri Lanka
Regulatory approvals
Status
Approved
Date of Approval
2021-06-21
Approval number
ERC/2021/13
Details of Ethics Review Committee
Name: | Ethics Review Committee of the Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka |
Institutional Address: | Faculty of Medicine and Allied Sciences, Rajarata University of Sri Lanka, Saliyapura. |
Telephone: | +94 252053633 |
Email: | ethicsreviewcommittee@gmail.com |
Contact person for Scientific Queries/Principal Investigator
Y.M.N.M.Wickramasinghe
Temporary Lecturer
Faculty of Medicine and Allied Sciences
Rajarata University of Sri Lanka
Saliyapura.
0252227706
0714576313
nadeeshawick1987@gmail.com
Contact Person for Public Queries
Prof. Sisira Siribaddana
Senior Professor
Faculty of Medicine and Allied Health Sciences, Rajarata University of Sri Lanka
Saliyapura
0252227706
0777326940
sisira.siribaddana@gmail.com
Primary study sponsor/organization
Higher degree, Research and Publication Committee
Faculty of Medicine and Allied Sciences,
Rajarata University of Sri Lanka,
Saliyapura.
0252234462
0252234464
deanfmas@yahoo.com
Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?
No
IPD sharing plan description
Study protocol available
No
Protocol version and date
Not Available
Protocol URL
Not Available
Results summary available
No
Date of posting results
Date of study completion
Final sample size
Date of first publication
Link to results
Brief summary of results
Terminated.